TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Cannabis Stocks Cruise After House Panel Votes to End Federal Ban
JIM CRAMER

Canopy Growth, Shopify, Thermo Fisher Scientific: 'Mad Money' Lightning Round

Good News Is Good News: Cramer's 'Mad Money' Recap (Tuesday 11/12/19)
JIM CRAMER

Safe From Trade Troubles: Cramer's 'Mad Money' Recap

Wright Medical Soars After Deal to Be Acquired by Stryker for $5.4 Billion
INVESTING

Alder Biopharmaceuticals Surges on Lundbeck Offer

Dow Futures Rise Amid Mixed Trade Deal Signals; Home Depot Outlook Pares Gains
JIM CRAMER

Go for the Easy Money: Cramer's 'Mad Money' Recap

Coca-Cola, Tesla, EPR Properties: 'Mad Money' Lightning Round
JIM CRAMER

Coca-Cola, Tesla, EPR Properties: 'Mad Money' Lightning Round

Fed Watch Begins: Jim Cramer Talks Trump's Tweets and Facebook's Cryptocurrency
JIM CRAMER

Bullish Jobs Data: Cramer's 'Mad Money' Recap

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
JIM CRAMER

Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

How High Can This Market Go?: Cramer's 'Mad Money' Recap (Friday 1/12/18)
JIM CRAMER

How High Can This Market Go?: Cramer's 'Mad Money' Recap

Alder BioPharmaceuticals: Cramer's Top Takeaways
STOCKS

Alder BioPharmaceuticals: Cramer's Top Takeaways

Here's a Look at 11 Upcoming IPOs in 2017
STOCKS

IPOs that should be on your radar

Sell Here! Chart Says You Have the Green Light to Seize the Day
JIM CRAMER

Market Signals Change of Direction: Cramer's 'Mad Money' Recap

CRH Edges Higher After Group Sees Boost from Trump Infrastructure Spending
JIM CRAMER

U.S. Concrete, Alder Biopharmaceuticals: 'Mad Money' Lightning Round

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Impax Shares Jump On FDA Approval for Generic Version of Concerta

Alder BioPharmaceuticals: Cramer's Top Takeaways
STOCKS

Alder BioPharmaceuticals: Cramer's Top Takeaways

'I Love the Down-and-Outers': Cramer's 'Mad Money' Recap (Thursday 7/13/17)
JIM CRAMER

'I Love the Down-and-Outers': Cramer's 'Mad Money' Recap (Thursday 7/13/17)

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Ocular, Alder, Flexion

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Alder Shares Drop Despite Positive Data for Migraine Prevention Drug

Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers
STOCKS

Pharmaceutical Stocks Gain on Promising Migraine Drugs with Hefty Price Tags

Endo's Potential Next Steps After Pulling Opioid Pain Med
HEALTH

Biotech Movers: Endo, Inovio, Alder

Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not Enough to Quell Value Debate
HEALTH

Novartis, Amgen Divvy Global Marketing of New Migraine Drug

Can Home Depot Hammer Out Solid Results Tuesday?
JIM CRAMER

Home Depot, Federal Realty, more: 'Mad Money' Lightning Round

AveXis, Esperion and Amgen Among Biotech Movers
STOCKS

Amgen shares skyrocket on surprise patent victory

Allergan's Fourth-Quarter Comments Should Comfort Investors
MERGERS AND ACQUISITIONS

Allergan's boldness may not be limited to tobira deal

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
STOCKS

16 Biopharma Companies Besides Medivation That Are Attractive Targets

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
MERGERS AND ACQUISITIONS

Xenoport's cost-cutting tactics lead to buyout with hefty premium